$CNA: CNA Financial Corp (CNA) Q3 Earnings Conference Call Transcript

Date: Monday, November 5th, 2018

Stock(s) mentioned:

Source: Motley Fool (https://www.fool.com)

Summary: Logo of jester cap with thought bubble with words ‘Fool Transcripts’ below it. Image source: The Motley Fool. CNA Financial Corporation (NYSE:CNA) Q3 2018 …

Full article address: https://www.fool.com/earnings/call-transcripts/2018/11/05/cna-financial-corp-cna-q3-earnings-conference-call.aspx

Related News:

$NGHC $HALL $CNA $CINF $AFG: P&C Insurance Outlook: Excess Capital, Rate Hike to Drive Growth

$EIG $AFL $AMSF $CNA: Aflac (AFL) Hits New 52-Week High: Is Further Upside Left?

$CNA: CNA Financial Corporation (NYSE:CNA): 3 Days To Buy Before The …

$L $CNA $SPX $DO: Loews Stock Doesn’t Get Any Respect, Says CEO Tisch

$CNA: CNA Financial Corporation (CNA) CEO Dino Robusto on Q1 2019 …

$CNA: CNA Financial Corp (CNA) Q1 2019 Earnings Call Transcript

$TRV $PGR $RLI $CNA: CNA Financial (CNA) Q1 Earnings Top, Investment Income Up

$CNA: CNA Financial Q1 net investment income returns 4.5%

$CNA: CNA Financial Announces First Quarter 2019 Results

$RE $CNA $RNR $ALL: CNA Financial (CNA) to Report Q1 Earnings: What’s in Store?

$HIG $L $CNA $DO: What’s in the Cards for Loews (L) This Earnings Season?

Latest News:

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences

$JFIN: 3 Reasons iQiyi Held Up Better Than Baidu